Benjamin T. Dake is SEE REMARKS at Aerovate Therapeutics, Inc. (AVTE). They have made 18 open-market trades across 1 company since 2022, most recently 2024-08-01.
CIK 0001869248
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 18 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AVTE | 14,252 | $38K |
Shares reported on the most recent Form 4, priced at the 2024-08-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AVTE | SELL · 10b5-1 | 2024-04-17 | 2024-04-19 | $22.35 | $297K | -5.7% | -8.7% | -91.8% |
| AVTE | SELL · 10b5-1 | 2024-04-01 | 2024-04-03 | $31.97 | $213K | -14.6% | -31.5% | -94.5% |
| AVTE | SELL · 10b5-1 | 2024-03-27 | 2024-03-28 | $27.97 | $619K | -11.2% | -32.5% | -95.3% |
| AVTE | SELL · 10b5-1 | 2024-03-25 | 2024-03-27 | $28.01 | $192K | -3.3% | -25.0% | -95.0% |
| AVTE | SELL · 10b5-1 | 2024-03-18 | 2024-03-20 | $25.90 | $1.8M | +12.9% | -15.8% | -94.6% |
| AVTE | SELL · 10b5-1 | 2023-12-06 | 2023-12-07 | $16.11 | $331K | +15.2% | +17.8% | +41.9% |
| AVTE | SELL · 10b5-1 | 2023-11-27 | 2023-11-29 | $16.24 | $407K | +3.9% | +41.4% | +48.6% |
| AVTE | SELL · 10b5-1 | 2023-11-22 | 2023-11-27 | $15.37 | $441K | +4.1% | +51.6% | +29.6% |
| AVTE | SELL · 10b5-1 | 2023-09-06 | 2023-09-08 | $15.06 | $119K | -5.5% | -5.9% | +20.6% |
| AVTE | SELL · 10b5-1 | 2023-08-07 | 2023-08-09 | $15.50 | $310K | -6.1% | -11.3% | -20.7% |
| AVTE | SELL · 10b5-1 | 2023-07-06 | 2023-07-07 | $16.66 | $343K | -7.2% | -12.6% | -22.0% |
| AVTE | SELL · 10b5-1 | 2023-06-06 | 2023-06-08 | $16.28 | $335K | -0.1% | +8.2% | -10.2% |
| AVTE | SELL · 10b5-1 | 2023-05-08 | 2023-05-09 | $21.71 | $412K | -16.2% | -24.7% | -31.0% |
| AVTE | SELL | 2023-04-06 | 2023-04-07 | $18.17 | $374K | -0.3% | +20.5% | -9.3% |
| AVTE | SELL | 2023-03-06 | 2023-03-08 | $23.72 | $483K | -13.2% | -24.2% | -31.9% |
| AVTE | SELL | 2023-02-06 | 2023-02-08 | $24.56 | $470K | +5.5% | -14.7% | -15.1% |
| AVTE | SELL | 2023-01-06 | 2023-01-09 | $25.98 | $534K | -3.0% | +3.9% | -26.3% |
| AVTE | SELL · 10b5-1 | 2022-12-12 | 2022-12-14 | $29.43 | $61K | +13.3% | +1.7% | -7.1% |
| AVTE | SELL | 2022-12-08 | 2022-12-12 | $22.77 | $443K | -11.7% | -15.1% | -26.2% |
| AVTE | SELL | 2022-12-06 | 2022-12-08 | $17.67 | $707K | +1.5% | -2.0% | -4.4% |
| AVTE | SELL | 2022-11-09 | 2022-11-14 | $19.13 | $506K | -5.5% | +30.2% | +19.5% |
| AVTE | SELL | 2022-11-07 | 2022-11-09 | $18.14 | $886K | -2.2% | +37.7% | +42.1% |
| AVTE | SELL | 2022-10-18 | 2022-10-20 | $21.08 | $241K | +4.6% | -4.8% | +28.9% |
| AVTE | SELL | 2022-10-14 | 2022-10-18 | $20.16 | $171K | -6.4% | -8.2% | +18.7% |
| AVTE | SELL | 2022-10-10 | 2022-10-12 | $16.83 | $143K | +27.2% | +18.7% | +59.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.